Viewing Study NCT00738569


Ignite Creation Date: 2025-12-24 @ 11:02 PM
Ignite Modification Date: 2026-05-21 @ 10:08 AM
Study NCT ID: NCT00738569
Status: COMPLETED
Last Update Posted: 2021-01-19
First Post: 2008-08-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Assess the Downregulation of HIV-1 When Raltegravir is Added to a Virologically Suppressed HAART Regimen
Sponsor: National Jewish Health
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: Merck HIV
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View